Sloan Sheldon
SEC insider (Form 3/4/5 filer). CIK 0002038798. Chief Medical Officer at Spyre Therapeutics, Inc. (SYRE). 18 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in WALTHAM, MA.
Companies Sloan Sheldon has filed insider reports for
- Spyre Therapeutics, Inc. (SYRE): Officer, Chief Medical Officer
Sloan Sheldon
CIK: 0002038798
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Spyre Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jul 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect6.5K shares at avg. $87.52$569K - Jul 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect1.8K shares at avg. $88.34$162K - Jul 1, 2026SYRE
Spyre Therapeutics, Inc.
ExerciseDirect8.3K shares at avg. $27.46$229K - Jun 3, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect8.3K shares at avg. $75.00$625K - Jun 3, 2026SYRE
Spyre Therapeutics, Inc.
ExerciseDirect8.3K shares at avg. $27.46$229K - May 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect8.8K shares at avg. $71.56$628K - May 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect12.8K shares at avg. $72.94$932K - May 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect10.4K shares at avg. $73.74$764K - May 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect5.1K shares at avg. $74.60$377K - May 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect400 shares at avg. $75.37$30K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 6,500 | $87.52 | $568,880 | Direct |
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 1,834 | $88.34 | $162,016 | Direct |
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc. | Exercise | 8,334 | $27.46 | $228,852 | Direct |
| Jun 3, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 8,333 | $75.00 | $624,975 | Direct |
| Jun 3, 2026 | SYRE Spyre Therapeutics, Inc. | Exercise | 8,333 | $27.46 | $228,824 | Direct |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 8,777 | $71.56 | $628,082 | Direct |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 12,777 | $72.94 | $931,954 | Direct |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 10,358 | $73.74 | $763,799 | Direct |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 5,059 | $74.60 | $377,401 | Direct |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 400 | $75.37 | $30,148 | Direct |
1-10 of 18 transactions